BTG3 and Hepatic fibrosis: Additionally, the APRI score, a non-invasive index commonly used to assess liver fibrosis, was significantly elevated in ANA-positive patients, supporting a potential link between ANA positivity and increased fibrosis risk in pediatric MASLD.